Impact of introducing HbA1c into the diagnostic criteria on prevalence and cardiovascular risk profiles of individuals with newly diagnosed diabetes in Japan: The Toranomon Hospital Health Management Center Study 2 (TOPICS 2)

Diabetes Research and Clinical Practice

Volumn 95, Issue 2, 2012, Pages 283-290

  Heianza, Yoriko ^a,b   Hara, Shigeko ^b,c   Arase, Yasuji ^b,c   Saito, Kazumi ^a,b   Tsuji, Hiroshi ^b,c   Kodama, Satoru ^a,b   Hsieh, Shiun Dong ^b,c   Mori, Yasumichi ^c   Okubo, Minoru ^c   Yamada, Nobuhiro ^a   Kosaka, Kinori ^b,c   Sone, Hirohito ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

CVD risk factors; Diagnostic criteria; HbA1c

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIET RESTRICTION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84856323917     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.10.024     Document Type: Article

References (35)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
2. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 2010, 53:450-467.
3. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus Abbreviated Report of a WHO Consultation, http://www.who.int/diabetes/publications/report-hba1c_2011.pdf.
4. Carson A.P., Reynolds K., Fonseca V.A., Muntner P. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010, 33:95-97.
5. Lorenzo C., Haffner S.M. Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2010, 33:335-337.
6. Boronat M., Saavedra P., Lopez-Rios L., Riano M., Wagner A.M., Novoa F.J. Differences in cardiovascular risk profile of diabetic subjects discordantly classified by diagnostic criteria based on glycated hemoglobin and oral glucose tolerance test. Diabetes Care 2010, 33:2671-2673.
7. Borg R., Vistisen D., Witte D.R., Borch-Johnsen K. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study. Diabet Med 2010, 27:906-910.
8. Wang W., Lee E.T., Howard B.V., Fabsitz R.R., Devereux R.B., Welty T.K. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study. Diabetes Care 2011, 34:363-368.
9. Balkau B., Soulimane S., Lange C., Gautier A., Tichet J., Vol S. Are the same clinical risk factors relevant for incident diabetes defined by treatment, fasting plasma glucose, and HbA1c?. Diabetes Care 2011, 34:957-959.
10. Torrens J.I., Skurnick J., Davidow A.L., Korenman S.G., Santoro N., Soto-Greene M., et al. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 2004, 27:354-361.
11. Matsumoto K., Miyake S., Yano M., Ueki Y., Yamaguchi Y., Akazawa S., et al. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care 1997, 20:1562-1568.
12. Kim D.J., Lee M.S., Kim K.W., Lee M.K. Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus. Metabolism 2001, 50:590-593.
13. Suzuki H., Fukushima M., Usami M., Ikeda M., Taniguchi A., Nakai Y., et al. Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia. Diabetes Care 2003, 26:1211-1215.
14. Selvin E., Zhu H., Brancati F.L. Elevated A1C in adults without a history of diabetes in the U.S. Diabetes Care 2009, 32:828-833.
15. Christensen D.L., Witte D.R., Kaduka L., Jorgensen M.E., Borch-Johnsen K., Mohan V., et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010, 33:580-582.
16. Herman W.H., Ma Y., Uwaifo G., Haffner S., Kahn S.E., Horton E.S., et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007, 30:2453-2457.
17. Kim C.H., Kim H.K., Bae S.J., Park J.Y., Lee K.U. Discordance between fasting glucose-based and hemoglobin A1c-based diagnosis of diabetes mellitus in Koreans. Diabetes Res Clin Pract 2011, 91:e8-e10.
18. Heianza Y., Hara S., Arase Y., Saito K., Totsuka K., Tsuji H., et al. Low serum potassium levels and risk of type 2 diabetes: the Toranomon Hospital Health Management Center Study 1 (TOPICS 1). Diabetologia 2011, 54:762-766.
19. Waki K., Noda M., Sasaki S., Matsumura Y., Takahashi Y., Isogawa A., et al. Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I. Diabet Med 2005, 22:323-331.
20. Yamagata H., Kiyohara Y., Nakamura S., Kubo M., Tanizaki Y., Matsumoto T., et al. Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population: the Hisayama study. Diabetes Care 2005, 28:789-794.
21. Nakagami T., Tajima N., Oizumi T., Karasawa S., Wada K., Kameda W., et al. Hemoglobin A1c in predicting progression to diabetes. Diabetes Res Clin Pract 2010, 87:126-131.
22. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
23. Kim C., Bullard K.M., Herman W.H., Beckles G.L. Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2010, 33:780-785.
24. Costa B., Barrio F., Cabre J.J., Pinol J.L., Cos F.X., Sole C., et al. Shifting from glucose diagnostic criteria to the new HbA(1c) criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population. Diabet Med 2011, 28:1234-1237.
25. Bernal-Lopez M.R., Santamaria-Fernandez S., Lopez-Carmona D., Tinahones F.J., Mancera-Romero J., Pena-Jimenez D., et al. HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice. Diabet Med 2011, 28:1319-1322.
26. Dickinson S., Colagiuri S., Faramus E., Petocz P., Brand-Miller J.C. Postprandial hyperglycemia and insulin sensitivity differ among lean young adults of different ethnicities. J Nutr 2002, 132:2574-2579.
27. Murakami K., Sasaki S., Takahashi Y., Okubo H., Hosoi Y., Horiguchi H., et al. Dietary glycemic index and load in relation to metabolic risk factors in Japanese female farmers with traditional dietary habits. Am J Clin Nutr 2006, 83:1161-1169.
28. Beckman J.A., Creager M.A., Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002, 287:2570-2581.
29. Selvin E., Coresh J., Golden S.H., Boland L.L., Brancati F.L., Steffes M.W. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care 2005, 28:1965-1973.
30. McNeely M.J., McClelland R.L., Bild D.E., Jacobs D.R., Tracy R.P., Cushman M., et al. The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis. Diabetes Care 2009, 32:1727-1733.
31. Gerstein H.C., Anand S., Yi Q.L., Vuksan V., Lonn E., Teo K., et al. The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study. Diabetes Care 2003, 26:144-149.
32. Saad M.F., Lillioja S., Nyomba B.L., Castillo C., Ferraro R., De Gregorio M., et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991, 324:733-739.
33. Harris S.B., Naqshbandi M., Bhattacharyya O., Hanley A.J., Esler J.G., Zinman B. Major gaps in diabetes clinical care among Canada's First Nations: results of the CIRCLE study. Diabetes Res Clin Pract 2011, 92:272-279.
34. Saltevo J.T., Kautiainen H., Niskanen L., Oksa H., Puolijoki H., Sundvall J., et al. Ageing and associations of fasting plasma glucose and 2h plasma glucose with HbA(1C) in apparently healthy population, " FIN-D2D" study. Diabetes Res Clin Pract 2011, 93:344-349.
35. Selvin E., Steffes M.W., Gregg E., Brancati F.L., Coresh J. Performance of A1C for the classification and prediction of diabetes. Diabetes Care 2011, 34:84-89.